Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 1.593T	--
--	2025/Q4	-- / 1.697T	--
Feb 10, 2025	2025/Q3	1.659T / 1.663T	--
Nov 8, 2024	2025/Q2	1.616T / 1.552T	--
Aug 6, 2024	2025/Q1	1.536T / 1.483T	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 1.593T--

--2025/Q4-- / 1.697T--

Feb 10, 20252025/Q31.659T / 1.663T--

Nov 8, 20242025/Q21.616T / 1.552T--

Aug 6, 20242025/Q11.536T / 1.483T--

Unlock Free Earnings Estimates

Open Account

SoftBank Earnings Reports

SoftBank: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [IFRS] (consolidated)

Feb 10 01:30 ET

SoftBank: Semi-annual report - 39th period (April 1, 2024 - March 31, 2025)

Nov 12, 2024 01:30 ET

SoftBank: Confirmation letter

Nov 12, 2024 01:30 ET

SoftBank: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [IFRS] (consolidated)

Nov 8, 2024 01:30 ET

Symbol Price % Chg

D. Western Therapeutics Institute

Allied Telesis Holdings KK

6835

190 +21.79%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Feb 17, 2025

Buy

Strong Buy
33.33%
Buy
16.67%
Hold
50.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data